Company Overview
Snapshot
Founded in October 2018 by Roey Shafrir, Spinol Medical operates with 1–10 employees. The company has developed a novel implantable annulus closure device and is currently advancing its OctaSeal product into FDA review, backed by five-year clinical data.
Business overview
Spinol Medical is a Health Tech & Life Sciences company specializing in medical devices, particularly in the orthopedic and minimally invasive surgery sectors. The company has developed OctaSeal, a novel implantable annulus closure device designed to seal ruptured spinal discs and prevent reherniation following lumbar discectomy. This minimally invasive system expands within the disc space and anchors via a self-deploying, tissue-sparing fixation mechanism, targeting hospitals, healthcare providers, and clinics.
Strategic signal
In December 2025, Spinol Medical advanced its OctaSeal product into FDA review. This move is significant as it indicates the company's progress toward regulatory approval for its minimally invasive intradiscal annular closure technology, supported by five-year clinical data, signaling potential market entry and validation for its innovative approach to spinal care.
Log in to access full profile ›Company Intelligence Q&A
- What is Spinol Medical's core product?
- Spinol Medical's core product is OctaSeal, a novel implantable annulus closure device designed to seal ruptured spinal discs and eliminate the risk of reherniation after lumbar discectomy.
- When was Spinol Medical founded?
- Spinol Medical was founded in October 2018.
- Who is a founder of Spinol Medical?
- Roey Shafrir is a founder of Spinol Medical.
- What is the current status of the OctaSeal product?
- In December 2025, Spinol Medical advanced its OctaSeal product into FDA review, supported by five-year clinical data.
- What problem does OctaSeal address?
- OctaSeal addresses the problem of re-herniation following lumbar discectomy by providing a minimally invasive annular closure system that seals ruptured spinal discs.